Caris Life Sciences Inc
(CAI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,034 | 26,735 | 59,998 | 64,520 | 64,281 |
| Depreciation Amortization | 109,654 | 117,178 | 82,386 | 72,191 | 52,394 |
| Income taxes - deferred | 1,138 | 4,967 | 2,170 | 3,205 | 6,014 |
| Accounts receivable | -1,175 | 4,733 | -6,397 | 7,404 | -10,492 |
| Other Working Capital | -1,757 | -4,779 | -559 | -9,401 | -3,719 |
| Other Operating Activity | 15,362 | -1,465 | 2,089 | -13,733 | -1,648 |
| Operating Cash Flow | $129,256 | $147,369 | $139,687 | $124,186 | $106,830 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -185,174 | -323,264 | -241,674 | -279,135 | -480,297 |
| Net Acquisitions | -16,059 | -4,100 | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | N/A | 10,320 |
| Other Investing Activity | 19,633 | 22,116 | 16,319 | 12,329 | 8,758 |
| Investing Cash Flow | $-181,600 | $-305,248 | $-225,355 | $-266,806 | $-461,219 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 552,540 | 748,731 | 372,510 | 588,870 | 1,035,381 |
| Debt Repayment | -496,270 | -581,739 | -245,136 | -406,961 | -699,161 |
| Common Stock Issued | 0 | 4,747 | 141 | 1,819 | 51,543 |
| Common Stock Repurchased | -9,176 | -12,997 | -31,395 | 0 | 0 |
| Other Financing Activity | -1,515 | -2,206 | -978 | -11,627 | -29,680 |
| Financing Cash Flow | $45,579 | $156,536 | $95,142 | $172,101 | $358,083 |
| Exchange Rate Effect | -674 | 75 | -1,394 | -1,411 | -101 |
| Beginning Cash Position | 59,765 | 53,821 | 45,741 | 17,671 | 14,078 |
| End Cash Position | 52,326 | 52,553 | 53,821 | 45,741 | 17,671 |
| Net Cash Flow | $-7,439 | $-1,268 | $8,080 | $28,070 | $3,593 |
| Free Cash Flow | |||||
| Operating Cash Flow | 129,256 | 147,369 | 139,687 | 124,186 | 106,830 |
| Capital Expenditure | -251,247 | -389,414 | -307,311 | -312,204 | -524,603 |
| Free Cash Flow | -121,991 | -242,045 | -167,624 | -188,018 | -417,773 |